Jubilant Pharmova Ltd (JUBLPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 525933, "name": "Jubilant Pharmo", "stock_name": "Jubilant Pharmo", "full_name": "Jubilant Pharmova Ltd", "name_url": "stocks-analysis/jubilant-pharmo", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "962.70", "chg": 30.7, "chgp": "3.29%", "dir": 1, "prev_price": "932.00", "mcapval": "15,334.00 Cr", "mcap": "Small Cap", "scripcode": 530019, "symbol": "JUBLPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE700A01033", "curr_date": "Aug 10, 03:54 PM", "curr_time": "16:14 PM", "last_traded_at": "Aug 10, 03:54 PM IST", "bse_nse_vol": "3.8 lacs", "exc_status": "Active", "traded_date": "Aug 10, 2026", "traded_date_str": "2026 08 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jubilant-pharmo-525933-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "When is the next results date for Jubilant Pharmova Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jubilant-pharmova-ltd-4140458", "imagepath": "", "date": "2026-08-06 23:18:29", "description": "The next results date for Jubilant Pharmova Ltd is scheduled for August 10, 2026...." }, { "title": "Jubilant Pharmova Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-faces-bearish-momentum-amid-technical-downgrade-4134553", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JubilantPharmov_technicaldot_4134553.png", "date": "2026-08-04 08:04:52", "description": "Jubilant Pharmova Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 21 July 2026. The stock’s recent price action and technical indicators signal a bearish trend, reflecting growing investor caution amid broader market pressures and sector-specific challenges." }, { "title": "Jubilant Pharmova Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-is-rated-sell-4132376", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JubilantPharmov_mojoScore_4132376.png", "date": "2026-08-02 10:10:03", "description": "Jubilant Pharmova Ltd is rated Sell by MarketsMOJO, with this rating last updated on 21 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 02 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "When is the next results date for Jubilant Pharmova Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jubilant-pharmova-ltd-4130770", "imagepath": "", "date": "2026-07-31 23:16:46", "description": "The next results date for Jubilant Pharmova Ltd is scheduled for August 7, 2026...." }, { "title": "Jubilant Pharmova Falls 5.89%: 2 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-falls-589-2-key-factors-driving-the-weekly-decline-4121269", "imagepath": "", "date": "2026-07-26 11:01:52", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>20 Jul:</strong> Stock opens at Rs.1,023.95 with marginal gain</p>\n <p><strong>21 Jul:</strong> Downgrade to Sell announced; stock drops 2.78%</p>\n <p><strong>22 Jul:</strong> Technical momentum shift highlighted; stock declines further</p>\n <p><strong>24 Jul:</strong> Week closes at Rs.962.00, down 0.91% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,022.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.962.00..." }, { "title": "Jubilant Pharmova Ltd Downgraded to Sell Amid Technical and Financial Weakness", "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-downgraded-to-sell-amid-technical-and-financial-weakness-4114598", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JubilantPharmov_mojoScore_4114598.png", "date": "2026-07-22 08:09:11", "description": "Jubilant Pharmova Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 21 July 2026. This change reflects a combination of deteriorating technical indicators, flat financial performance, and subdued long-term growth prospects, despite an attractive valuation relative to peers." }, { "title": "Jubilant Pharmova Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-4114368", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JubilantPharmov_technicaldot_4114368.png", "date": "2026-07-22 08:01:26", "description": "Jubilant Pharmova Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, moving from a mildly bullish to a mildly bearish trend. This change accompanies a 2.78% decline in its share price to ₹995.45 on 22 Jul 2026, reflecting growing investor caution despite the company’s strong long-term returns relative to the Sensex." }, { "title": "Jubilant Pharmova Gains 6.38%: 3 Key Factors Driving the Weekly Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/jubilant-pharmova-gains-638-3-key-factors-driving-the-weekly-rally-4107592", "imagepath": "", "date": "2026-07-18 17:04:02", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> Stock opens strong at ₹973.85, up 1.35%</p>\n <p><strong>15 Jul:</strong> Sharp price surge of 5.49% to ₹1,027.40 amid technical momentum shift</p>\n <p><strong>16 Jul:</strong> Mixed technical signals noted, with sideways to mildly bullish trend emerging</p>\n <p><strong>17 Jul:</strong> Upgrade to Hold rating announced, stock closes at ₹1,022.25</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.960.90</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week ..." }, { "title": "Jubilant Pharmova Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/jubilant-pharmova-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-4105797", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JubilantPharmov_mojoScore_4105797.png", "date": "2026-07-17 08:03:18", "description": "Jubilant Pharmova Ltd has seen its investment rating upgraded from Sell to Hold as of 16 July 2026, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing challenges in financial performance and market returns. This reassessment by MarketsMOJO highlights a shift in the company’s technical trend to mildly bullish, alongside an attractive valuation relative to peers, balanced against flat quarterly results and subdued long-term growth." } ], "total": 416, "sid": "525933", "stock_news_url": "https://www.marketsmojo.com/news/jubilant-pharmova-525933" }, "announcements": [ { "details": "Jubilant Life Sciences Limited has informed the Exchange regarding 'Partial Early Redemption of 4.875% Senior Notes Due 2021 by Jubilant Pharma Limited, wholly-owned subsidiary of the Company (a company incorporated under the laws of Singapore)'.", "source": "NSE", "caption": "Jubilant Life Sciences Limited - Updates", "datetime": "22-Nov-2019" }, { "details": "Jubilant Life Sciences Limited has informed the Exchange regarding 'We enclose a communication pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. '.", "source": "NSE", "caption": "Jubilant Life Sciences Limited - Updates", "datetime": "21-Nov-2019" }, { "details": "Jubilant Life Sciences Limited has informed the Exchange regarding 'Securities Appellate Tribunal Order", "source": "NSE", "caption": "Jubilant Life Sciences Limited - Updates", "datetime": "08-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "", "data": [ { "title": "BOARD MEETING", "txt": "(10 Aug 2026)" } ] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Jubilant Pharmova Ltd has declared <strong>500%</strong> dividend, ex-date: 24 Jul 26", "dt": "2026-07-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Jubilant Pharmova Ltd has announced <strong>1:5</strong> stock split, ex-date: 17 Mar 06", "dt": "2006-03-17", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

20 Jul: Stock opens at Rs.1,023.95 with marginal gain

21 Jul: Downgrade to Sell announced; stock drops 2.78%

22 Jul: Technical momentum shift highlighted; stock declines further

24 Jul: Week closes at Rs.962.00, down 0.91% on the day

Read full news article

Jubilant Pharmova Ltd Downgraded to Sell Amid Technical and Financial Weakness

2026-07-22 08:09:11

Jubilant Pharmova Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 21 July 2026. This change reflects a combination of deteriorating technical indicators, flat financial performance, and subdued long-term growth prospects, despite an attractive valuation relative to peers.

Read full news article

Jubilant Pharmova Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals

2026-07-22 08:01:26

Jubilant Pharmova Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, moving from a mildly bullish to a mildly bearish trend. This change accompanies a 2.78% decline in its share price to ₹995.45 on 22 Jul 2026, reflecting growing investor caution despite the company’s strong long-term returns relative to the Sensex.

Read full news article

Jubilant Pharmova Gains 6.38%: 3 Key Factors Driving the Weekly Rally

2026-07-18 17:04:02

Key Events This Week

13 Jul: Stock opens strong at ₹973.85, up 1.35%

15 Jul: Sharp price surge of 5.49% to ₹1,027.40 amid technical momentum shift

16 Jul: Mixed technical signals noted, with sideways to mildly bullish trend emerging

17 Jul: Upgrade to Hold rating announced, stock closes at ₹1,022.25

Week Open

Rs.960.90

Week ...

Read full news article

Jubilant Pharmova Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-07-17 08:03:18

Jubilant Pharmova Ltd has seen its investment rating upgraded from Sell to Hold as of 16 July 2026, reflecting a nuanced improvement across technical indicators and valuation metrics despite ongoing challenges in financial performance and market returns. This reassessment by MarketsMOJO highlights a shift in the company’s technical trend to mildly bullish, alongside an attractive valuation relative to peers, balanced against flat quarterly results and subdued long-term growth.

Read full news article

View All News